Boceprevir versus placebo with pegylated interferon alfa-2b...

The Lancet Infectious Diseases 2013 / 07 Vol. 13; Iss. 7

Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial

Sulkowski, Mark, Pol, Stanislas, Mallolas, Josep, Fainboim, Hugo, Cooper, Curtis, Slim, Jihad, Rivero, Antonio, Mak, Carmen, Thompson, Seth, Howe, Anita YM, Wenning, Larissa, Sklar, Peter, Wahl, Janic
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Language:
english
Journal:
The Lancet Infectious Diseases
DOI:
10.1016/S1473-3099(13)70149-X
Date:
July, 2013
File:
PDF, 333 KB
english, 2013
Conversion to is in progress
Conversion to is failed